Updated NCCN Clinical Practice Guidelines in Oncology now recognize that MammaPrint and BluePrint testing can help identify a ...
The NCCN guidelines now include MammaPrint for identifying HR+/HER2- early-stage breast cancer patients who may benefit from ...
New NCCN guidelines recognize the utility of MammaPrint for guiding anthracycline therapy selection in HR+/HER2- early-stage ...
An individual-patient meta-analysis sheds light on the optimal duration of androgen deprivation therapy in men with prostate cancer on definitive radiotherapy.
Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced an agreement with the ...
National Clinical Trials Network (NCTN) group focused on improving outcomes for adults with cancer through multi-center clinical research, recently announced changes in leadership across multiple ...
Patients’ financial resources affect their enrollment in oncology clinical trials to a greater degree than traditional ...
MedPage Today on MSN
Gastric Cancer's Individualized Patient-Centered Treatment Approach
The specifics of endoscopic/surgical resection and perioperative treatment ...
Dr Benson, Robert H. Lurie Comprehensive Cancer Center, explores the importance of philanthropy and the power it has to drive ...
Michael David Chuong, MD, discusses how SBRT has become a leading option for treating patients with colorectal liver ...
Breast screening, also called mammography, is a business. A great idea at that — it can benefit people both in finding cancer ...
Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced an agreement with the National Comprehensive Cancer Network ® (NCCN ® ). This collaboration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback